Back to Trades
Norwalk Leslie V
DirectorCIK 0001533568
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 4
- Active
- 2025–2026
Across 9 filings between 2025–2026, Norwalk Leslie V, Director, has disclosed $2.3M in transactions — spread across 4 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.2M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 30 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Sell | $227.5K |
| Jun 26 | ARVN ARVINAS, INC. | Norwalk Leslie V | Director | Grant | $182.8K |
| Jun 8 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Sell | $210.1K |
| May 29 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Award | $408.9K |
| May 21 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Exercise | $0 |
| May 15 | CVS CVS HEALTH Corp | Norwalk Leslie V | Director | Grant | $140.6K |
| May 14 | NBIX NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V | Director | Sell | $590.6K |
| Jan 12 | GMED GLOBUS MEDICAL INC | Norwalk Leslie V | Insider | Sell | $202.2K |
| Nov 21 | CVS CVS HEALTH Corp | Norwalk Leslie V | Director | Grant | $125.6K |
9 filings